News
Oxygen Therapy for Mild COPD: Is It Beneficial?
Researchers find oxygen therapy does not improve quality of life, forestall hospitalization, lengthen lives
Your search for supplemental oxygen returned 10 results
News
Close to 1,900 Cases of Vaping-Linked Lung Illness Reported, CDC Says
The related death toll has also risen by three during the past week, to 37 fatalities.
News
CDC: Cases of Vaping-Linked Lung Illness Now Top 1600
Related death toll has also risen to 34 fatalities, spread across 24 states
News
More Than 800 Cases of Vaping-Linked Illness Reported in 46 States
US Centers for Disease Control and Prevention also reports 12 confirmed deaths in 10 states.
News
Efficacy of High-Flow O2 Tx Test Outside ICU for Infants With Bronchiolitis?
The researchers found that 12% of infants in the high-flow group received escalation of care due to treatment failure versus 23% in the standard-therapy group.
Drug News
Support for Narrow-Spectrum Antibiotics in Pediatric Pneumonia
Narrow-spectrum antibiotics, which are recommended as first-line therapy for children hospitalized with community-acquired pneumonia (CAP), show similar outcomes compared with broad-spectrum antibiotics.
News
Double-Dose Oseltamivir Not Beneficial in Severe Influenza
For patients with severe influenza, double-dose oseltamivir has no benefit over standard-dose treatment.
News
Azithromycin Delays Next Hospitalization in COPD
For patients with chronic obstructive pulmonary disease (COPD) hospitalized for a respiratory-related event, administration of azithromycin is associated with a prolonged time to next respiratory hospitalization.
Drug News
ATS Issues Top Five Choosing Wisely Recommendations
The top five pulmonology-related issues that physicians and patients should question have been released by the American College of Chest Physicians and American Thoracic Society (ATS) as part of the Choosing Wisely campaign.
Drugs in the Pipeline
Phase 2a study of FG-4592 for the treatment of anemia associated with chronic kidney disease (CKD)
FibroGen announced data from its Phase 2a study of FG-4592 (oral anemia therapy) in patients with stage 3-4 chronic kidney disease (CKD) and anemia.
